TID 10022 Radiopharmaceutical Administration Event Data
Prev | Radiopharmaceutical Radiation Dose SR IOD Templates | Next

### TID 10022 Radiopharmaceutical Administration Event Data

The Radiopharmaceutical Administration Event conveys the dose and assay and time information of a single radiopharmaceutical event. A Radiopharmaceutical Administration event is one radioactive pharmaceutical administered to a patient.

Type:

  Extensible

Order:

  Significant

Table TID 10022. Radiopharmaceutical Administration Event Data

| NL | Rel with Parent | VT | Concept Name | VM | Req Type | Condition | Value Set Constraint
--- | --- | --- | --- | --- | --- | --- | --- | ---
1 |  |  | CONTAINER | EV (113502, DCM, "Radiopharmaceutical Administration") | 1 | M |  |
2 | > | CONTAINS | CODE | EV (F-61FDB, SRT, "Radiopharmaceutical agent") | 1 | M |  | DCID 25 “Radiopharmaceuticals” DCID 4021 “PET Radiopharmaceutical”
3 | >> | HAS PROPERTIES | CODE | EV (C-10072, SRT, "Radionuclide") | 1 | M |  | DCID 18 “Isotopes in Radiopharmaceuticals” DCID 4020 “PET Radionuclide”
4 | >> | HAS PROPERTIES | NUM | EV (R-42806, SRT, "Radionuclide Half Life") | 1 | M |  | UNITS = EV (s, UCUM, "seconds")
5 | > | CONTAINS | NUM | EV (123007, DCM, "Radiopharmaceutical Specific Activity") | 1 | U |  | UNITS = EV (Bq/mmol, UCUM, "Bq/mmol")
6 | > | CONTAINS | UIDREF | EV (113503, DCM, "Radiopharmaceutical Administration Event UID") | 1 | M |  |
7 | > | CONTAINS | CODE | EV (113505, DCM, "Intravenous Extravasation Symptoms") | 1-n | U |  | DCID 10043 “Intravenous Extravasation Symptoms”
8 | > | CONTAINS | NUM | EV (113506, DCM, "Estimated Extravasation Activity") | 1 | U |  | UNITS = EV(%, UCUM, "percent")
9 | > | CONTAINS | DATETIME | EV (123003, DCM, "Radiopharmaceutical Start DateTime") | 1 | M |  |
10 | > | CONTAINS | DATETIME | EV (123004, DCM, "Radiopharmaceutical Stop DateTime") | 1 | U |  |
11 | > | CONTAINS | NUM | EV (113507, DCM, "Administered activity") | 1 | M |  | UNITS = EV (MBq, UCUM, "MBq")
12 | > | CONTAINS | NUM | EV (123005, DCM, "Radiopharmaceutical Volume") | 1 | U |  | UNITS = EV (cm3, UCUM, "cm3")
13 | > | CONTAINS | NUM | EV (113508, DCM, "Pre-Administration Measured Activity") | 1 | U |  | UNITS = EV (MBq, UCUM, "MBq")
14 | >> | HAS OBS CONTEXT | CODE | EV (113540, DCM, "Activity Measurement Device") | 1 | U |  | DCID 10041 “Source of Radioisotope Activity Information”
15 | >> | HAS OBS CONTEXT | INCLUDE | DTID 1002 “Observer Context” | 1-n | U |  |
16 | > | CONTAINS | NUM | EV (113509, DCM, "Post-Administration Measured Activity") | 1 | U |  | UNITS = EV (MBq, UCUM, "MBq")
17 | >> | HAS OBS CONTEXT | CODE | EV (113540, DCM, "Activity Measurement Device") | 1 | U |  | DCID 10041 “Source of Radioisotope Activity Information”
18 | >> | HAS OBS CONTEXT | INCLUDE | DTID 1002 “Observer Context” | 1-n | U |  |
19 | > | CONTAINS | INCLUDE | DTID 10023 “Organ Dose” | 1-n | U |  |
20 | > | CONTAINS | CODE | EV (G-C340, SRT, "Route of administration") | 1 | M |  | BCID 11 “Route of Administration”
21 | >> | HAS PROPERTIES | CODE | EV (G-C581, SRT, "Site of") | 1 | MC | IF Row 22 equals (G-D101, SRT, "Intravenous route") or (G-D103, SRT, "Intramuscular route") | DCID 3746 “Percutaneous Entry Site”
22 | >>> | HAS CONCEPT MOD | CODE | EV (G-C171, SRT, "Laterality") | 1 | MC | IF Row 23 has laterality | DCID 244 “Laterality”
23 | > | HAS OBS CONTEXT | INCLUDE | DTID 1020 “Person Participant” | 1-n | M |  | $PersonProcedureRole = EV (113851, DCM, "Irradiation Administering")
24 | > | CONTAINS | CODE | EV (121147, DCM, "Billing Code(s) ") | 1-n | U |  |
25 | > | CONTAINS | CODE | EV (113510, DCM, "Drug Product Identifier") | 1-n | U |  |
26 | > | CONTAINS | TEXT | EV (111529, DCM, "Brand Name") | 1 | U |  |
27 | > | CONTAINS | TEXT | EV (113511, DCM, "Radiopharmaceutical Dispense Unit Identifier") | 1 | U |  |
28 | >> | CONTAINS | TEXT | EV (113512, DCM, "Radiopharmaceutical Lot Identifier") | 1-n | U |  |
29 | >> | CONTAINS | TEXT | EV (113513, DCM, "Reagent Vial Identifier") | 1-n | U |  |
30 | >> | CONTAINS | TEXT | EV (113514, DCM, "Radionuclide Identifier") | 1-n | U |  |
31 | > | CONTAINS | TEXT | EV (113516, DCM, "Prescription Identifier") | 1 | U |  |
32 | > | CONTAINS | TEXT | EV (121106, DCM, "Comment") | 1 | U |  |

Content Item Descriptions

Row 4 | The value of Half-life that was used for computing the decay of the administered radiopharmaceutical. It is not intended for use by the receiver for any further computation.
Row 5 | Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time
Row 6 | Unique identification of a single radiopharmaceutical administration event.
Row 8 | The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site.
Row 9 | The time the radiopharmaceutical was administered to the patient for imaging purposes.
Row 11 | Total amount of radioactivity administered to the patient at Radiopharmaceutical Start Time. It is a computed field from the TID 10022 Pre-Administration Measured Activity Row 13, TID 10022 Post-Administration Measured Activity Row 17, Radionuclide Half Life Row 4 and Radiopharmaceutical Start Time Row 9. Does not include estimated extravasation activity.
Rows 13, 16 | Observation DateTime (0040,A032) shall be used to record when the measurement was taken.
Row 23 | Identifies the person administering the product.
Row 24 | The billing codes for the preparation and administration of the radiopharmaceutical. It does not include performance and interpretation of the imaging.
Row 25 | Registered drug establishment code for the product. A coding scheme example is NDC, WHO-DDE or RxNorm. Multiple entries can be used for equivalent drug product codes.
Row 27 | The human readable identification of the specific radiopharmaceutical quantity (dose) administered to the patient.
Row 28 | Identifies the vial, batch or lot number from which the individual radiopharmaceutical quantity (dose) was produced. Row 27 the Radiopharmaceutical Identifier records the identification for each individual dose.
Row 29 | Identifies the lot or unit serial number for the reagent component for the radiopharmaceutical identified in row 27.
Row 30 | Identifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical identified in row 27.

Prev | Up | Next
Radiopharmaceutical Radiation Dose SR IOD Templates | Home | TID 10023 Organ Dose